- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Helix Biomedix Inc
+ Add to WatchlistHXBM:US
24.5000 USD 0.00000.00%As of 20:10:00 ET on 05/23/2013.
Snapshot for Helix Biomedix Inc (HXBM)
| Open: | - | Day's Range: | - | Volume: | 200 |
|---|---|---|---|---|---|
| Previous Close: | 24.5000 | 52wk Range: | 7.6875 - 132.0000 | 1-Yr Rtn: | -72.78% |
Key Statistics for HXBM
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -15.0000 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 4.06 |
| Shares Outstanding (M) | 0.17 |
| 30 Day Average Volume | 15 |
| Price/Book (mrq) | 3.5309 |
| Price/Sale (ttm) | 1.9655 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 06/06/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for HXBM
Company Profile & Key Executives for HXBM
Helix BioMedix, Inc. is a biomedical research company. The Company conducts research on lytic peptides, small bioactive proteins that have the ability to destroy a spectrum of bacteria, protozoa, fungi, and viruses which cause pathogenic disease conditions in animals and humans.
| R Stephen BeattyPresident/CEO/Acting CFO | Robin L CarmichaelVP/COO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
HXBM News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page